NADPH oxidases (NOXs) and endothelial nitric oxide synthase (eNOS) can be activated by metabolic abnormalities of diabetic kidney disease, particularly hyperglycemia and hyperlipidemia, to impact oxidative stress [32]. Here, FMO5 is linked to hyperlipidemia.